These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature. Ito MK Atherosclerosis; 2015 Oct; 242(2):647-56. PubMed ID: 26296750 [TBL] [Abstract][Full Text] [Related]
5. The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia. Morton AM; Furtado JD; Lee J; Amerine W; Davidson MH; Sacks FM J Clin Lipidol; 2016; 10(6):1442-1451.e4. PubMed ID: 27919362 [TBL] [Abstract][Full Text] [Related]
6. Triglyceride as a risk factor for coronary artery disease. Gotto AM Am J Cardiol; 1998 Nov; 82(9A):22Q-25Q. PubMed ID: 9819100 [TBL] [Abstract][Full Text] [Related]
7. Rationale for prescription omega-3-acid ethyl ester therapy for hypertriglyceridemia: a primer for clinicians. Bays H Drugs Today (Barc); 2008 Mar; 44(3):205-46. PubMed ID: 18536782 [TBL] [Abstract][Full Text] [Related]
8. 'Trig-onometry': non-high-density lipoprotein cholesterol as a therapeutic target in dyslipidaemia. Jacobson TA Int J Clin Pract; 2011 Jan; 65(1):82-101. PubMed ID: 21105969 [TBL] [Abstract][Full Text] [Related]
9. Recommendations for severe hypertriglyceridemia treatment, are there new strategies? Filippatos TD; Elisaf MS Curr Vasc Pharmacol; 2014; 12(4):598-616. PubMed ID: 23627980 [TBL] [Abstract][Full Text] [Related]
10. Management of hypertriglyceridemia in the diabetic patient. Jialal I; Amess W; Kaur M Curr Diab Rep; 2010 Aug; 10(4):316-20. PubMed ID: 20532703 [TBL] [Abstract][Full Text] [Related]
11. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia. Stalenhoef AF; de Graaf J; Wittekoek ME; Bredie SJ; Demacker PN; Kastelein JJ Atherosclerosis; 2000 Nov; 153(1):129-38. PubMed ID: 11058707 [TBL] [Abstract][Full Text] [Related]
12. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin. Breuer HW Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448 [TBL] [Abstract][Full Text] [Related]
13. Hypertriglyceridemia and cardiovascular risk reduction. Jacobson TA; Miller M; Schaefer EJ Clin Ther; 2007 May; 29(5):763-777. PubMed ID: 17697898 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological management of high triglycerides and low high-density lipoprotein cholesterol. Szapary PO; Rader DJ Curr Opin Pharmacol; 2001 Apr; 1(2):113-20. PubMed ID: 11714084 [TBL] [Abstract][Full Text] [Related]
15. The role of triglycerides in cardiovascular risk. Gandotra P; Miller M Curr Cardiol Rep; 2008 Nov; 10(6):505-11. PubMed ID: 18950562 [TBL] [Abstract][Full Text] [Related]
16. Potential use of fenofibrate and other fibric acid derivatives in the clinic. Brown WV Am J Med; 1987 Nov; 83(5B):85-9. PubMed ID: 3688012 [TBL] [Abstract][Full Text] [Related]
18. Effects of niacin and omega-3 fatty acids on the apolipoproteins in overweight patients with elevated triglycerides and reduced HDL cholesterol. Savinova OV; Fillaus K; Harris WS; Shearer GC Atherosclerosis; 2015 Jun; 240(2):520-5. PubMed ID: 25932792 [TBL] [Abstract][Full Text] [Related]
19. The triglyceride connection in atherosclerosis. Geurian K; Pinson JB; Weart CW Ann Pharmacother; 1992 Sep; 26(9):1109-17. PubMed ID: 1421678 [TBL] [Abstract][Full Text] [Related]
20. [Residual risk: The roles of triglycerides and high density lipoproteins]. Grammer T; Kleber M; Silbernagel G; Scharnagl H; März W Dtsch Med Wochenschr; 2016 Jun; 141(12):870-7. PubMed ID: 27305303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]